{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:48:30Z","timestamp":1773272910887,"version":"3.50.1"},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,7,13]],"date-time":"2001-07-13T00:00:00Z","timestamp":994982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cellular Biochemistry"],"published-print":{"date-parts":[[2001,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The <jats:italic>oim<\/jats:italic> mouse is a model of human Osteogenesis Imperfecta (OI) that has deficient synthesis of pro\u03b12(I) chains. Cells isolated from <jats:italic>oim<\/jats:italic> mice synthesize \u03b11(I) collagen homotrimers that accumulate in tissues. To explore the feasibility of gene therapy for OI, a murine pro\u03b12(I) cDNA was inserted into an adenovirus vector and transferred into bone marrow stromal cells isolated from <jats:italic>oim<\/jats:italic> mice femurs. The murine cDNA under the control of the cytomegalovirus early promoter was expressed by the transduced cells. Analysis of the collagens synthesized by the transduced cells demonstrated that the cells synthesized stable type I collagen comprised of \u03b11(I) and \u03b12(I) heterotrimers in the correct ratio of 2:1. The collagen was efficiently secreted and also the cells retained the osteogenic potential as indicated by the expression of alkaline phosphatase activity when the transduced cells were treated with recombinant human bone morphogenetic protein 2. Injection of the virus carrying the murine pro\u03b12(I) cDNA into <jats:italic>oim<\/jats:italic> skin demonstrated synthesis of type I collagen comprised of \u03b11 and \u03b12 chains at the injection site. These preliminary data demonstrate that collagen genes can be transferred into bone marrow stromal cells as well as fibroblasts in vivo and that the genes are efficiently expressed. These data encourage further studies in gene replacement for some forms of OI and use of bone marrow stromal cells as vehicles to deliver therapeutic genes to bone. \u00a9 2001 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jcb.1209","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T20:41:50Z","timestamp":1030308110000},"page":"84-91","source":"Crossref","is-referenced-by-count":27,"title":["Transfer of pro\u03b12(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of \u03b11(I) and \u03b12(I) heterotrimers in vitro and in vivo"],"prefix":"10.1002","volume":"83","author":[{"given":"Christopher","family":"Niyibizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibao","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte L.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,8,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(97)00075-6"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.8.5142"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.43.020192.001413"},{"key":"e_1_2_6_5_1","first-page":"127","article-title":"Nitric oxide inhibits the synthesis of type II collagen without altering COL2A1 mRNA abundance: prolyl hydroxylase as a possible target","volume":"324","author":"Cao M","year":"1997","journal-title":"Biochem J"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100090504"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.5.1701"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00052a002"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5235.404"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-199507000-00021"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.17.3451"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/jvi.71.3.1842-1849.1997","article-title":"Construction of \u2010adenovirus vectors through Cre\u2010lox recombination","volume":"71","author":"Hardy S","year":"1997","journal-title":"J Virol"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/6529"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.14.6298"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.5.7.2010058"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00202a024"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.1997.03540330068037","article-title":"Osteogenesis Imperfecta: rehabilitation and prospects for gene therapy","volume":"277","author":"Marini JC","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950018157"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8493530"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.729"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1016\/S0021-9258(18)50063-6","article-title":"Incorporation of type I collagen molecules that contain a mutant (2(I) chain (Gly580\u2192 Asp) into bone matrix in a lethal case of Osteogenesis Imperfecta","volume":"267","author":"Niyibizi C","year":"1992","journal-title":"J Biol Chem"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300839"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.11.4857"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.3.1142"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12491894"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(92)90065-Z"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100090504"},{"key":"e_1_2_6_28_1","first-page":"440","article-title":"Mutations in type I procollagen genes: an explanation for brittle bones and a paradigm for other diseases of connective tissue","volume":"49","author":"Prockop DJ","year":"1990","journal-title":"Annu Rheum Dis"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5309.71"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.64.070195.002155"},{"key":"e_1_2_6_31_1","first-page":"89","article-title":"Mutations in type 1 procollagen that cause Osteogenesis Imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies","volume":"2","author":"Prockop DJ","year":"1993","journal-title":"J Bone Miner Res"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0094-1298(20)31017-8","article-title":"Molecular basis of Osteogenesis Imperfecta and related disorders of bone","volume":"21","author":"Prockop DJ","year":"1994","journal-title":"Clin Plast Surg"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112012"},{"key":"e_1_2_6_34_1","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1182\/blood.V81.10.2566.2566","article-title":"Long\u2010term engraftment of normal and post\u20105\u2010fluorouracil murine marrow into normal nonmyeleablated mice","volume":"81","author":"Stewart FM","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.45.1.149"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118434"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/18.7.1763"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.11.8.9240963"}],"container-title":["Journal of Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcb.1209","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcb.1209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T14:03:41Z","timestamp":1697465021000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcb.1209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,6]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["10.1002\/jcb.1209"],"URL":"https:\/\/doi.org\/10.1002\/jcb.1209","archive":["Portico"],"relation":{},"ISSN":["0730-2312","1097-4644"],"issn-type":[{"value":"0730-2312","type":"print"},{"value":"1097-4644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,6]]}}}